This report by Future Market Insights (FMI) examines the ‘Excimer and Femtosecond Ophthalmic Lasers Market for the period 2016–2024. The primary objective of the report is to offer updates and information related to market opportunities in the global excimer and femtosecond ophthalmic lasers market.
The excimer and femtosecond ophthalmic lasers market report begins by defining excimer and femtosecond laser systems. This is followed by an overview of dynamics of the global excimer and femtosecond ophthalmic lasers market, which includes FMI analysis of key trends, drivers, restraints, opportunities, regulations and reimbursement scenario that are influencing growth of the global excimer and femtosecond ophthalmic lasers market. This section also includes an insight into pricing of laser systems by region. Impact analyses of key growth drivers and restraints based on a weighted average model have been included after analysis of individual regions to provide meaningful insights to readers regarding ongoing developments in the market.
The primary factors fuelling demand for excimer and femtosecond laser systems include growing prevalence of diabetes and increasing ageing population globally. Other factors driving demand for excimer and femtosecond laser systems are increase in the number of cataract and refractive surgeries, which is resulting in an increasing number of ophthalmic laser systems in ophthalmology clinics and hospitals. Increasing number of new product launches and partnerships are other factors driving demand for excimer and femtosecond laser systems globally. However, a primary factor hampering growth of the global excimer and femtosecond laser systems market is the high cost associated with these products, which significantly increases the cost of cataract and refractive surgery.
Based on product type, the market has been segmented into excimer laser and femtosecond laser systems. A detailed analysis has been provided for every segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity and BPS analysis.
The report has been segmented based on various applications such as refractive surgery, cataract surgery, capsulotomy, trabeculoplasty and diagnostics. Our analysis predicts that moderate to high myopia would increase at a very fast pace, thus the number of refractive surgeries such as LASIK, PRK and LASEK are also anticipated to increase. Furthermore, demand for femtosecond and excimer lasers is expected to increase from ophthalmology clinics as more number of patients visit ophthalmology clinics for refractive and cataract surgeries. This trend is expected to be particularly prominent in emerging economies such as China, South Korea and India due to increasing access to public healthcare services in the region.
The next section of the report highlights excimer and femtosecond laser systems adoption by region and provides market outlook for 2016–2026. The report also discusses key regional trends contributing to growth of the global excimer and femtosecond ophthalmic lasers market, as well as analyses the extent to which drivers are influencing this market in each region. Key regions assessed in this report include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Ex. Japan, China and South Korea (ASEJCSK), Japan, China, South Korea and Middle East & Africa (MEA).
The above sections - by product type, application, end users and region - evaluate the current scenario and growth prospects of the global excimer and femtosecond ophthalmic lasers market for 2016-2026. We have considered 2015 as the base year and provided data for the forecast period, i.e., 2016-2026.
To ascertain global excimer and femtosecond ophthalmic lasers market size, we have considered revenue generated by laser machine manufacturing companies. The forecast presented here assesses the total revenue generated across the excimer and femtosecond ophthalmic lasers market. In order to offer an accurate forecast, we started by sizing up the current market, which forms the basis of how the excimer and femtosecond ophthalmic lasers market is expected to develop in the future. Given the characteristics of the market, we triangulated the outcome of three different types of analysis based on supply side, downstream industry demand and the economic envelope.
In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse based on key parameters such as year-on-year (Y-o-Y) growth rates to understand the predictability of the market and to identify the right opportunities across the global excimer and femtosecond ophthalmic lasers market.
The excimer and femtosecond ophthalmic laser segments in terms of product, application, end users and regions are analysed in terms of Basis Point Share (BPS) to understand individual segment’s relative contributions to market growth. This detailed level of information is important for identifying various key trends in the global excimer and femtosecond ophthalmic lasers market.
Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective.
To understand key growth segments in terms of growth and adoption of excimer and femtosecond lasers globally, Future Market Insights developed the ‘Attractiveness Index’. The resulting index should help providers identify real market opportunities.
In the final section of the report, a ‘Competitive Landscape’ has been included to provide report audiences with a dashboard view, based on categories and product portfolios of providers of excimer and femtosecond ophthalmic lasers systems, and key differentiators. Key categories of providers covered in the report are excimer and femtosecond ophthalmic laser manufacturers. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the excimer and femtosecond ophthalmic laser value chain, and the potential players for the same. Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on in-depth assessment of capabilities and successes in the global excimer and femtosecond ophthalmic lasers marketplace.
Detailed profiles of the key players in the global market have also been included in the scope of the report to evaluate long-term and short-term strategies, key offerings, SWOT analysis and the recent developments in the global excimer and femtosecond ophthalmic lasers market. Key players covered include Abbott Medical Optics, Inc., Alcon Inc., Bausch & Lomb Incorporated, NIDEK CO., LTD iVIS Technologies, ZEISS International, Ziemer Ophthalmic Systems AG, SCHWIND eye-tech-solutions GmbH & Co. KG and LENSAR, LLC.
Key Segments Covered
Product Type Excimer Laser Femtosecond Laser By Application Refractive Surgery Cataract Surgery Capsulotomy Trabeculoplasty Diagnostics By End-User Hospital Ambulatory Surgical Centers Ophthalmology Clinics
Key Regions/Countries Covered
North America U.S. Canada
Latin America Brazil Mexico Rest of Latin America
Western Europe U.K. Germany France Spain Italy Nordic Benelux Rest of Western Europe Eastern Europe Russia Poland Rest of Eastern Europe Asia Pacific Ex. Japan China & South Korea India Australia & New Zealand ASEAN Rest of APEJ Japan China South Korea Middle East & Africa GCC Southern Africa Rest of MEA
Abbott Medical Optics, Inc Alcon Inc. (Novartis AG) Bausch & Lomb Incorporated NIDEK CO., LTD. iVIS Technologies ZEISS International Ziemer Ophthalmic Systems AG SCHWIND eye-tech-solutions GmbH & Co. KG LENSAR, LLC.
Our reports have been used by over 10K customers, including:
Polycystic Kidney Disease - Global Clinical Trials Review, H1, 2021 Summary clinical trial report, “Polycystic Kidney Disease - Global Clinical Trials Review, H1, 2021" provides an overview of Polycystic Kidney Diseas Clinical trials scenario. This report provides top line data relating to the clinical...
Vascular Injury Treatment Market Research Report by Injury (Aneurysm & Pseudoaneurysm, Arteriovenous Fistula, Contusion or Intimal Flap, Laceration orTransection, and Spasm), by Treatment (Bypass Graft, Extra Anatomic Bypass, Lateral Arteriorrhaphy or Venorrhaphy, Patch Angioplasty, and Thrombectomy), by End User - Global Forecast...
Diabetes Drugs Market Research Report by Drug Type (Injectable Drug and Oral Drug), by Application (Type 1 Diabetes and Type 2 Diabetes) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and...
Joint Pain Injections Market Research Report by Injection Type (Corticosteroid Injections and Hyaluronic Acid Injections), by Joint Type (Facet Joints of the Spine, Hip Joint, Knee and Ankle, and Shoulder and Elbow), by Distribution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The...
Asthma Spacers Market Research Report by Product Type (Aerochamber, Inspirease, Optichamber, and Volumatic), by Distribution Channel (E-commerce, Hospital Pharmacy, and Retail Pharmacy) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across...
The Cardiovascular drug market studied was anticipated to grow with a CAGR of nearly 3.8% during the forecast period. The major factors driving the growth of the market are the rising global prevalence of various coronary heart diseases such as stroke, cardiomyopathy causing a global burden of cardiac deaths and favorable reimbursement initiatives....
The global albumin & creatinine tests market size is valued at an estimated USD 987 million in 2020 and is projected to reach USD 2,103 million by 2025, at a CAGR of 16.3% during the forecast period. The growth of the global albumin & creatinine tests market is driven by factors such as growing prevalence of kidney disorders, the rising adoption...
Post Menopausal Osteoporosis - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Post Menopausal Osteoporosis - Pipeline Review, H2 2020, provides an overview of the Post Menopausal Osteoporosis (Metabolic Disorders) pipeline landscape. Postmenopausal...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.